Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/145259| Author(s): | Mello, RA Zhu, JH Iavelberg, J Potim, AH Simonetti, D Júnior, JAS Castelo-Branco, P Pozza, DH Tajima, CC Tolia, M Antoniou, G |
| Title: | Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: Is there a role in clinical practice? |
| Publisher: | AME |
| Issue Date: | 2020 |
| DOI: | 10.21037/tlcr-20-625 |
| URI: | https://hdl.handle.net/10216/145259 |
| Source: | Translational Lung Cancer Research, vol.9(6), p. 2311-2314 |
| Document Type: | Artigo em Revista Científica Internacional |
| Rights: | openAccess |
| License: | https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.21037-tlcr-20-625.pdf | 162.86 kB | Adobe PDF |  View/Open |
This item is licensed under a Creative Commons License
